Mitochondrial enzymes act as catalysts in the electron transport chain, where electrons are transferred through a series of proteins embedded in the inner mitochondrial membrane. This process ultimately leads to the formation of a proton gradient that drives the synthesis of ATP. In individuals with MELAS syndrome, mutations can impair these enzymatic activities, leading to a deficiency in ATP production.
